Edison, NJ, United States of America

Elizabeth Ashley Rouse

This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2007-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Ashley Rouse. Retrieved from https://idiyas.com/inventor/elizabeth-ashley-rouse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Elizabeth Ashley Rouse

Introduction

Elizabeth Ashley Rouse is an accomplished inventor based in Edison, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target glucagon receptors. With a total of 2 patents, her work is focused on addressing critical health issues such as type 2 diabetes mellitus.

Latest Patents

Rouse's latest patents include "Benzamidazoles, compositions containing such compounds and methods of use" and "Cyclic guanidines, compositions containing such compounds and methods of use." The first patent relates to substituted benzimidazoles that serve as glucagon receptor antagonists, which are useful for treating, preventing, or delaying the onset of type 2 diabetes mellitus. The second patent also focuses on cyclic guanidines with similar therapeutic applications.

Career Highlights

Elizabeth Rouse is currently employed at Merck & Company, Inc., where she continues to innovate and develop new pharmaceutical solutions. Her expertise in medicinal chemistry has positioned her as a valuable asset in the research and development sector.

Collaborations

Some of her notable coworkers include Emma R Parmee and Ronald M Kim, who collaborate with her on various projects within the company.

Conclusion

Elizabeth Ashley Rouse's contributions to the field of pharmaceuticals through her innovative patents highlight her commitment to improving health outcomes. Her work exemplifies the impact of dedicated inventors in addressing significant medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…